Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
62,955.30 -215.51 (-0.34%) CMC Crypto 200
1,316.30 +39.32 (+3.08%)
Orange S.A. (ORAN)
After hours:
| Previous close | 11.09 |
| Open | 11.24 |
| Bid | 11.20 x 900 |
| Ask | 11.21 x 2200 |
| Day's range | 11.20 - 11.26 |
| 52-week range | 10.97 - 12.94 |
| Volume | |
| Avg. volume | 346,637 |
| Market cap | 29.826B |
| Beta (5Y monthly) | 0.11 |
| PE ratio (TTM) | 12.47 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.75 (6.68%) |
| Ex-dividend date | 30 Nov 2023 |
| 1y target est | N/A |
- Zacks
Orange (ORAN) & MASMOVIL to Transform Spain's Telecom Market
Orange (ORAN) and MASMOVIL form a joint venture to generate synergies of more than 490 million euros per year by the fourth year of closing.
- Zacks
Orange (ORAN) and Cisco Sign MoU to Reduce GHG Emission
Orange (ORAN) and Cisco sign a MoU that allows them to track emissions across their joint portfolio.
- Reuters SG
Deals of the day-Mergers and acquisitions
** Novo Nordisk notched a win in its race to boost output of its popular obesity drug Wegovy, with its parent company announcing it was buying Catalent, a key manufacturing subcontractor of the product, for $16.5 billion. ** Brazilian fashion companies Arezzo & Co and Grupo Soma said they had agreed to a merger to form an entity with yearly revenues of 12 billion reais ($2.42 billion), which will be 54% controlled by Arezzo. ** Drug maker Novartis AG is in advanced talks to acquire MorphoSys AG, a developer of cancer treatments that has a market value of 1.6 billion euros ($1.7 billion), two people familiar with the matter said.
